1. Cell Cycle/DNA Damage PI3K/Akt/mTOR
  2. DNA-PK
  3. KU-57788

KU-57788 (NU7441) is a highly potent and selective DNA-PK inhibitor with an IC50 of 14 nM. KU-57788 is an NHEJ pathway inhibitor. KU-57788 also inhibits PI3K and mTOR with IC50s of 5.0 and 1.7 μM, respectively.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 503468-95-9

容量 価格(税別) 在庫状況 数量
>無料サンプル (0.1 - 0.2 mg)   今すぐ申し込む  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 75 在庫あり
Solution
10 mM * 1 mL in DMSO USD 75 在庫あり
Solid
5 mg $69 在庫あり
10 mg $119 在庫あり
25 mg $220 在庫あり
50 mg $360 在庫あり
100 mg $532 在庫あり
250 mg $852 在庫あり
500 mg $1190 在庫あり
1 g   お問い合わせ  
5 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 42 publication(s) in Google Scholar

Top Publications Citing Use of Products

顧客検証

Flow Cytometry
Bio/Physico-chemical Assay
Cell Imaging/Staining
In Vivo Imaging
IHC
Cell Proliferation/Viability Assay
IP

    KU-57788 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Jun 3:e2400023.  [Abstract]

    NU7441 (0-2 μM; 24 h). Morphological changes of NHA/HRasV12/TRIM24 cells treated with NU7441 for 24 h at indicated concentrations.

    KU-57788 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Jun 3:e2400023.  [Abstract]

    NU7441 (20 mg/kg; ip). Representative bioluminescent (BLI) images of treated animals on day 10.

    KU-57788 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Jun 3:e2400023.  [Abstract]

    NU7441 (20 mg/kg; ip). Representative images showing H&E and IHC staining of brain cross sections of NHA/HRasV12/TRIM24‐derived tumors from animals treated with NU7441 or vehicle for 7 days.

    KU-57788 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Jun 3:e2400023.  [Abstract]

    NU7441 (0.01-100 μM; 48 h). Viability of NHA/HRasV12 cells with or without ectopic expression of TRIM24 at 48 h after treatment with NU7441.

    KU-57788 purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2024 Oct 22:e180278.  [Abstract]

    The tumor cell line was treated with DMSO or DNA-PKi (2 μM NU7441) for 48 hours, at which point the drug was washed off prior to coculturing with TILs at a 1:1 ratio for 18 hours. Cytotoxicity was determined by annexin V staining with flow cytometric gating on tumor cells (based on light scatter and CD3) and viability dye.

    KU-57788 purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2024 Oct 22:e180278.  [Abstract]

    B16-F10 melanoma cells were treated with 2 μM NU7441 or DMSO control for 72 hours, at which point gradual darkening was observed.

    KU-57788 purchased from MedChemExpress. Usage Cited in: Cell Metab. 2021 Oct 5;33(10):2076-2089.e9.  [Abstract]

    FHs 74 Int cells with expression of FLAG-TBK1 were pretreated with NU7441 (1 μM), KU55933 (10 μM),or AZD6738 (2μM) for 2h, and then exposed to 10 Gy ionizing radiation. Immunoprecipitation analyses with anti-FLAG M2 agarose beads were performed 30 min after irradiation.
    • 生物活性

    • プロトコル

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    KU-57788 (NU7441) is a highly potent and selective DNA-PK inhibitor with an IC50 of 14 nM. KU-57788 is an NHEJ pathway inhibitor. KU-57788 also inhibits PI3K and mTOR with IC50s of 5.0 and 1.7 μM, respectively[1].

    IC50 & Target[1]

    DNA-PK

    14 nM (IC50)

    mTOR

    1.7 μM (IC50)

    PI3K

    5.0 μM (IC50)

    CRISPR/Cas9

     

    Cellular Effect
    Cell Line Type Value Description References
    CHO IC50
    14 3
    Compound: 2, NU7441
    Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay
    Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay
    [PMID: 23855836]
    CHO IC50
    14 3
    Compound: 2, NU7441
    Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay
    Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay
    [PMID: 23855836]
    CHO IC50
    14 3
    Compound: 2, NU7441
    Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay
    Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay
    [PMID: 23855836]
    Cortical neurone EC50
    1.2 3
    Compound: NU7441
    Neuroprotective activity in rat cortical neurons transfected with an mHTT-exon1-Q73 construct in presence of primary corticostriatal co-culture system assessed as rescue from mHTT-induced survival loss by fluorescent reporter based assay
    Neuroprotective activity in rat cortical neurons transfected with an mHTT-exon1-Q73 construct in presence of primary corticostriatal co-culture system assessed as rescue from mHTT-induced survival loss by fluorescent reporter based assay
    [PMID: 30840447]
    Cortical neurone EC50
    1.2 3
    Compound: NU7441
    Neuroprotective activity in rat cortical neurons transfected with an mHTT-exon1-Q73 construct in presence of primary corticostriatal co-culture system assessed as rescue from mHTT-induced survival loss by fluorescent reporter based assay
    Neuroprotective activity in rat cortical neurons transfected with an mHTT-exon1-Q73 construct in presence of primary corticostriatal co-culture system assessed as rescue from mHTT-induced survival loss by fluorescent reporter based assay
    [PMID: 30840447]
    Cortical neurone EC50
    1.2 3
    Compound: NU7441
    Neuroprotective activity in rat cortical neurons transfected with an mHTT-exon1-Q73 construct in presence of primary corticostriatal co-culture system assessed as rescue from mHTT-induced survival loss by fluorescent reporter based assay
    Neuroprotective activity in rat cortical neurons transfected with an mHTT-exon1-Q73 construct in presence of primary corticostriatal co-culture system assessed as rescue from mHTT-induced survival loss by fluorescent reporter based assay
    [PMID: 30840447]
    HeLa EC50
    212 1
    Compound: 2, NU7441
    Inhibition of DNA-PK autophosphorylation at S2056 in human HeLa cells
    Inhibition of DNA-PK autophosphorylation at S2056 in human HeLa cells
    [PMID: 23855836]
    HeLa IC50
    14 1
    Compound: Chemical Probe: NU7441
    Inhibition of human HeLa cell nuclear extract purified DNA-PK using p53 peptide as substrate by ELISA
    Inhibition of human HeLa cell nuclear extract purified DNA-PK using p53 peptide as substrate by ELISA
    [PMID: 16707462]
    LoVo GI50
    0.52 3
    Compound: Chemical Probe: NU7441
    Growth inhibition of human LoVo cells measured after 5 days by crystal violet staining based assay
    Growth inhibition of human LoVo cells measured after 5 days by crystal violet staining based assay
    [PMID: 16707462]
    体外実験

    NU7441 (0.5 to 10 μM) inhibits the growth of liver cancer HepG2 cells dose- and time-dependently. NU7441 reduces pDNA-PKcs (S2056) protein expression in liver cancer cells. Furthermore, double treatment of NU7441 and 60Coγ IR affects DNA damage repair[2].
    NU7441 is solvent-exposed in BRD4, this inhibitor can be classified as a Type I BRD inhibitor[4].
    NU7441 reduces the frequency of NHEJ while increasing the rate of HDR following Cas9-mediated DNA cleavage[5].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    分子量

    413.49

    分子式

    C25H19NO3S

    CAS 番号
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=C1C=C(N2CCOCC2)OC3=C1C=CC=C3C4=CC=CC5=C4SC6=C5C=CC=C6

    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : 6.67 mg/mL (16.13 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.4184 mL 12.0922 mL 24.1844 mL
    5 mM 0.4837 mL 2.4184 mL 4.8369 mL
    10 mM 0.2418 mL 1.2092 mL 2.4184 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 0.67 mg/mL (1.62 mM); Clear solution

      This protocol yields a clear solution of ≥ 0.67 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (6.7 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 0.67 mg/mL (1.62 mM); Clear solution

      This protocol yields a clear solution of ≥ 0.67 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (6.7 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    純度とドキュメンテーション

    純度: 99.95%

    参考文献
    細胞実験
    [2]

    HepG2 cells (4000 per well) are cultured in a 96-well plate for 24 h. Once the cells complete the attachment, 0.1 µM, 1 µM, 5 µM, and 10 µM of KU-57788 are added to the culture media. After 12 h of KU-57788 treatment, 10% CCK-8 solution is added into the culture media, and the incubation continued for two h. OD450 values are determined by a spectrometer, and the results are analyzed to measure the cell growth.

    MedChemExpress (MCE) はこれらの方法の精度を確認していません。 こちらは参照専用です。

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.4184 mL 12.0922 mL 24.1844 mL 60.4610 mL
    5 mM 0.4837 mL 2.4184 mL 4.8369 mL 12.0922 mL
    10 mM 0.2418 mL 1.2092 mL 2.4184 mL 6.0461 mL
    15 mM 0.1612 mL 0.8061 mL 1.6123 mL 4.0307 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    KU-57788
    製品番号:
    HY-11006
    数量:
    MCE 日本正規代理店: